04 Oct 2012
News – Shares in Xvivo Perfusion AB will begin trading on NASDAQ OMX First North on October 8, 2012
Shares in Xvivo Perfusion AB will begin trading on NASDAQ OMX First North on October 8, 2012
Read moreNews - Page 7
24 Sep 2012
Information regarding the distribution of Xvivo Perfusion AB
In accordance with the resolution adopted by the Extraordinary General Meeting of shareholders held on September 24, Vitrolife’s…
Read more 10 Jul 2012
Application for market approval of STEEN SolutionTM in the USA has been submitted to the FDA
Vitrolife has submitted an application to the American Food and Drug Administration (FDA) regarding market approval of STEEN…
Read more